Nonetheless, for new GLP-1 drugs in development, it is imperative to evaluate potential drug interactions since this drug class can alter the efficacy of concomitant medications or increase the risk of adverse events as a result of higher exposure to a co-administrated drug
References 1 AllagnatF.FukayaM.NogueiraT
We represent 200 storefronts in 90 local jurisdictions and also Canacraft and March and Ash, a vertically integrated cannabis business
All licensed GLP-1 medicationssuch as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)are administered via subcutaneous injection or, in limited cases, as oral tablets
Marys Hospital, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 06591, Korea E-mail: [email protected] Copyright 2024 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited